India · Delayed Price · Currency is INR Sakar Healthcare Statistics
Total Valuation
NSE:SAKAR has a market cap or net worth of INR 17.88 billion. The enterprise value is 18.58 billion.
| Market Cap | 17.88B |
| Enterprise Value | 18.58B |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:SAKAR has 22.25 million shares outstanding. The number of shares has increased by 1.07% in one year.
| Current Share Class | 22.25M |
| Shares Outstanding | 22.25M |
| Shares Change (YoY) | +1.07% |
| Shares Change (QoQ) | -0.46% |
| Owned by Insiders (%) | 52.41% |
| Owned by Institutions (%) | n/a |
| Float | 4.93M |
Valuation Ratios
The trailing PE ratio is 58.66 and the forward PE ratio is 36.20.
| PE Ratio | 58.66 |
| Forward PE | 36.20 |
| PS Ratio | 7.10 |
| PB Ratio | 5.51 |
| P/TBV Ratio | 5.64 |
| P/FCF Ratio | 85.53 |
| P/OCF Ratio | 36.30 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 26.98, with an EV/FCF ratio of 88.89.
| EV / Earnings | 60.96 |
| EV / Sales | 7.38 |
| EV / EBITDA | 26.98 |
| EV / EBIT | 41.00 |
| EV / FCF | 88.89 |
Financial Position
The company has a current ratio of 1.28, with a Debt / Equity ratio of 0.22.
| Current Ratio | 1.28 |
| Quick Ratio | 0.46 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | 1.02 |
| Debt / FCF | 3.37 |
| Interest Coverage | 5.77 |
Financial Efficiency
Return on equity (ROE) is 10.00% and return on invested capital (ROIC) is 8.88%.
| Return on Equity (ROE) | 10.00% |
| Return on Assets (ROA) | 6.32% |
| Return on Invested Capital (ROIC) | 8.88% |
| Return on Capital Employed (ROCE) | 12.20% |
| Weighted Average Cost of Capital (WACC) | 6.43% |
| Revenue Per Employee | 7.36M |
| Profits Per Employee | 891,363 |
| Employee Count | 342 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 2.17 |
Taxes
In the past 12 months, NSE:SAKAR has paid 92.71 million in taxes.
| Income Tax | 92.71M |
| Effective Tax Rate | 23.32% |
Stock Price Statistics
The stock price has increased by +123.91% in the last 52 weeks. The beta is 0.38, so NSE:SAKAR's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | +123.91% |
| 50-Day Moving Average | 699.42 |
| 200-Day Moving Average | 484.01 |
| Relative Strength Index (RSI) | 55.91 |
| Average Volume (20 Days) | 154,489 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:SAKAR had revenue of INR 2.52 billion and earned 304.85 million in profits. Earnings per share was 13.70.
| Revenue | 2.52B |
| Gross Profit | 1.28B |
| Operating Income | 453.24M |
| Pretax Income | 397.55M |
| Net Income | 304.85M |
| EBITDA | 688.88M |
| EBIT | 453.24M |
| Earnings Per Share (EPS) | 13.70 |
Balance Sheet
The company has 2.60 million in cash and 705.34 million in debt, with a net cash position of -702.74 million or -31.58 per share.
| Cash & Cash Equivalents | 2.60M |
| Total Debt | 705.34M |
| Net Cash | -702.74M |
| Net Cash Per Share | -31.58 |
| Equity (Book Value) | 3.24B |
| Book Value Per Share | 145.98 |
| Working Capital | 309.22M |
Cash Flow
In the last 12 months, operating cash flow was 492.58 million and capital expenditures -283.52 million, giving a free cash flow of 209.06 million.
| Operating Cash Flow | 492.58M |
| Capital Expenditures | -283.52M |
| Depreciation & Amortization | 235.65M |
| Net Borrowing | -222.41M |
| Free Cash Flow | 209.06M |
| FCF Per Share | 9.40 |
Margins
Gross margin is 51.03%, with operating and profit margins of 18.00% and 12.11%.
| Gross Margin | 51.03% |
| Operating Margin | 18.00% |
| Pretax Margin | 15.79% |
| Profit Margin | 12.11% |
| EBITDA Margin | 27.37% |
| EBIT Margin | 18.00% |
| FCF Margin | 8.30% |
Dividends & Yields
NSE:SAKAR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.07% |
| Shareholder Yield | -1.07% |
| Earnings Yield | 1.70% |
| FCF Yield | 1.17% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |